Bio-Medical Applications Of North Carolina Inc is categorized under Kidney Dialysis Centers in Zebulon, NC .
Bio-Medical Applications Of North Carolina Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 621492 by the NAICS.
If you are seeking more information, feel free to contact Jenny Dillon at the company’s branch by writing to 465 Stratford Drive, Zebulon, North Carolina NC 27597 or by phoning (919) 269-8889. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bio-Medical Applications Of North Carolina Inc |
| Contact Person: | Jenny Dillon |
| Address: | 465 Stratford Drive, Zebulon, North Carolina 27597 |
| Phone Number: | (919) 269-8889 |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Kidney Dialysis Centers |
| SIC Code: | 8092 |
| NAICS Code: | 621492 |
| Share This Business: |
Bio-Medical Applications Of North Carolina Inc was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 621492. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Jenny Dillon for inquiries that concern Bio-Medical Applications Of North Carolina Inc by calling the company number (919) 269-8889, as your correspondence is most welcome. Additionally, the physical location of the branch of Bio-Medical Applications Of North Carolina Inc can be found at the coordinates 35.822683,-78.324941 as well as the street address 465 Stratford Drive in Zebulon, North Carolina 27597.
For its online presence, you may visit Bio-Medical Applications Of North Carolina Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.